• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
54,116 results

TwinStrand Biosciences, Inc. v. Guardant Health, Inc.

Docket 24-1626, U.S. Court of Appeals, Federal Circuit (Apr. 1, 2024)
Appellant TWINSTRAND BIOSCIENCES, INC.
Appellee GUARDANT HEALTH, INC.
Twinstrand Biosciences, Inc.
...
cite Cite Docket

Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al

Docket 1:24-cv-00571, Delaware District Court (May 10, 2024)
Judge Gregory B. Williams, presiding
Patent
DivisionWilmington
FlagsPATENT
Cause35:271 Patent Infringement
Case Type830 Patent
Tags830 Patent, 830 Patent
Plaintiff Breckenridge Pharmaceutical, Inc.
Defendant Hetero USA Inc.
Defendant Hetero Labs Limited Unit - III
...
cite Cite Docket

Takeda Vaccines, Inc. v. Valneva Austria GmbH

Docket IPR2023-00354, Patent Trial and Appeal Board (Dec. 27, 2022)
Jamie Wisz, Robert Pollock, Wesley Derrick, presiding
Case TypeInter Partes Review
Patent11219681
Patent Owner Valneva Austria GmbH
Petitioner Takeda Vaccines, Inc.
Assignee WILMINGTON TRUST, NATIONAL ASSOCIATION
cite Cite Docket

Scale Biosciences, Inc. v. Parse Biosciences, Inc. et al

Docket 1:22-cv-01597, Delaware District Court (Dec. 14, 2022)
Judge Christopher J. Burke, presiding
Patent
DivisionWilmington
FlagsMulti-Media Docs, PATENT
Cause35:1 Patent Infringement
Case Type830 Patent
Tags830 Patent, 830 Patent
DeadlineRelease of Transcript Restriction set for 4/9/2025.
Deadline30th May Christopher J. Burke UNITED STATES MAGISTRATE JUDGE 7 Event Close of fact discovery Final supplement identifying all accused products and all invalidity references Final infringement contentions Final invalidity contentions Case Narrowing Step One: Initial narrowing of asserted claims to no more than 32 claims for Plaintiffs and 24 claims for Counterclaim Plaintiffs Opening expert reports Rebuttal expert reports Reply expert reports Close of discovery, including expert discovery Case Narrowing Step Two: Narrowing of asserted claims to no more than 24 claims for Plaintiffs and 18 claims for Counterclaim Plaintiffs Case dispositive & Daubert motions Hearing on case dispositive & Daubert motions Case Narrowing Step Three: Narrowing of asserted claims to no more than 16 claims for Plaintiffs and 12 claims for Counterclaim Plaintiffs Joint Proposed Pretrial Order (incorporating motions in limine) Proposed preliminary and final jury instructions, voir dire, and special verdict forms Pretrial conference Tri, 13. (Case Narrowing Step Three) The parties shall narrow the asserted claims to no more than 16 claims for Plaintiffs and 12 claims for Counterclaim Plaintiffs by April 11, 2025 with those claims selected from those identified by the parties at Case Narrowing Step Two
Plaintiff Scale Biosciences, Inc.
Plaintiff Roche Sequencing Solutions, Inc.
Defendant Parse Biosciences, Inc.
...
cite Cite Docket

Pierre Fabre Medicament SAS, et al. v. Annora Pharma Private Limited

Docket 1:22-cv-01442, Delaware District Court (Nov. 2, 2022)
Judge Jennifer L. Hall, presiding
Patent - Abbreviated New Drug Application (ANDA)
DivisionWilmington
FlagsCLOSED, PATENT
Cause35:271 Patent Infringement
Case Type835 Patent - Abbreviated New Drug Application (ANDA)
Tags835 Patent, Abbreviated New Drug Application, Anda, 835 Patent, Abbreviated New Drug Application, Anda
DeadlineDate of Expiration of Patent: 10/16/2028.Thirty Month Stay Deadline: 3/19/2025.
Plaintiff Pierre Fabre Medicament SAS
Plaintiff Centre Hospitalier Universitaire de Bordeaux
Plaintiff Pierre Fabre Pharmaceuticals, Inc.
...
cite Cite Docket

TwinStrand Biosciences, Inc. v. Guardant Health, Inc.

Docket IPR2022-01400, Patent Trial and Appeal Board (Aug. 12, 2022)

cite Cite Docket

Guardant Health, Inc. v. University of Washington

Docket IPR2022-01388, Patent Trial and Appeal Board (Aug. 10, 2022)

cite Cite Docket

Guardant Health, Inc. v. University of Washington

Docket IPR2022-01159, Patent Trial and Appeal Board (July 12, 2022)

cite Cite Docket
1 2 3 4 5 ... >>